For 30 years, the Rheumatology Research Foundation has been funding research and advancing treatments. During that time, Leonard L. Dragone, MD, PhD, received a Foundation award to help look for new strategies to treat autoimmune and inflammatory diseases in mouse models. Then, he was working as an assistant professor of pediatrics and immunology at the…
In 1984, I wrote my first prescription for the antimalarial drug, hydroxychloroquine (Plaquenil), for a 28-year-old woman with SLE. She was considerably overweight, with inflammatory arthritis and a photosensitive rash, and I worried that oral corticosteroids would tip her over into diabetes. I presented the case to my attending, Steven Malawista, MD, at the Yale…
Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information
Plus, updates on buprenorphine, diclofenac sodium, secukinumab and other rheumatology drug news, safety information
Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication
Rheumatologists must be adequately compensated for managing patients with complex drug therapies and Medicare beneficiaries need access to biologic treatments
The FDA modifies rituximab prescribing information to stress risk of hepatitis B virus reactivation
Plus, rheumatology drug news, safety updates
How to manage the risks when prescribing medications for patients in chronic pain
Rheumatology experts review history of LN, offer explanations for roadblocks to better therapies